Clinical Infectious Diseases
Study findings from St. Antonius Hospital provide new insights into clinical infectious diseases
Published in Hospital Business Week, July 19th, 2009
"Symptoms improved within 1 week. No relapses were observed," wrote B.L. Herpers and colleagues, St. Antonius Hospital.
The researchers concluded: "This favorable outcome suggests that tigecycline might be a useful alternative for treating severe refractory CDI."
Herpers and colleagues published the results of their research in Clinical Infectious Diseases (Intravenous Tigecycline as Adjunctive or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Agency for Healthcare Research & Quality
New Snapshots Show States Vary Widely in Providing Quality Health Care - Annuloplasty
ATS Medical Announces FDA Clearance and First Implant of New ATS Simulus Semi-Rigid Annuloplasty Band - Association of Organ Procurement Organizations
Dr. Dan Lebovitz of Ohio Receives Leadership Award - Behavior
MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP, Group Account Director - Betsy McCaughey; Committee to Reduce Infection Deaths
McCaughey Urges Use of First NYS Hospital Infection Report - Bio-Matrix Scientific Group Inc.
Bio-Matrix Scientific Group Inc. Named “Stock Pick” by WallStreetCorner.com -- Hospital and University Research Demand for Bio-Matrix’s Stem Cell Bank Cited - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
